Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on October 20, 2026

25 minutes ago

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

Indeterminate GlobeNewswire

27 minutes ago

Medicovestor Announces FDA Fast Track Designation for MC001, Its First-in-Class Chemoimmunotherapy ADC for Pancreatic Cancer

Indeterminate GlobeNewswire

33 minutes ago

The Consortium for Top-Down Proteomics is now The Proteoform Alliance, with the Expanded Mission to Unlock the Full Potential of Proteoform Biology

Indeterminate GlobeNewswire

35 minutes ago

Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026

Indeterminate GlobeNewswire

35 minutes ago

Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call

Indeterminate GlobeNewswire

an hour ago

Kane Biotech Signs Distribution Agreement with The Stevens Company

Indeterminate GlobeNewswire

an hour ago

PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026

Indeterminate GlobeNewswire

an hour ago

Mammogen Names National Cancer Screening Leader, Dr. Rebecca Kaltman, to Lead Pivotal genTRU-breast™ Study

Indeterminate GlobeNewswire

an hour ago

Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026

Indeterminate GlobeNewswire

an hour ago

Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia

Indeterminate GlobeNewswire

an hour ago

Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young

Indeterminate GlobeNewswire

an hour ago

ABBYY Introduces PHOENIX Plus, Advanced AI Models Optimized for Intelligent Document Processing

Indeterminate GlobeNewswire

an hour ago

Abiologics Appoints Per Jr. Greisen as Chief Artificial Intelligence Officer

Indeterminate GlobeNewswire

an hour ago

Matternet Expands NHS Drone Delivery Network to Great Ormond Street Hospital

Indeterminate GlobeNewswire

an hour ago

Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026

Indeterminate GlobeNewswire

an hour ago

BioNTech veröffentlicht am 3. November 2026 Ergebnisse für das dritte Quartal 2026 und informiert über operativen Fortschritt

Indeterminate GlobeNewswire

an hour ago

BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026

Indeterminate GlobeNewswire

2 hours ago

Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy

Indeterminate GlobeNewswire

2 hours ago

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study

Indeterminate GlobeNewswire

2 hours ago

Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania

Indeterminate GlobeNewswire